Dr. Stephan Kendall, MD
Claim this profileUtah Cancer Specialists
Studies Prostate Cancer
Studies Fallopian Tube Cancer
9 reported clinical trials
22 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
2Fallopian Tube Cancer
Stage IV
BRCA positive
HRD positive
Affiliated Hospitals
Clinical Trials Stephan Kendall, MD is currently running
Mezigdomide Combo vs. Pomalidomide Combo
for Multiple Myeloma
This trial is testing two drug combinations to find out which one is better and safer for patients with multiple myeloma that has come back or not responded to previous treatments. The drugs work together to kill cancer cells by stopping their growth, helping the immune system attack them, and making it harder for them to survive.
Recruiting2 awards Phase 3
Zenocutuzumab
for Non-Small Cell Lung and Prostate Cancers
This is a Phase II, open-label, 2-arm, multicenter, international study designed to evaluate the efficacy of zenocutuzumab alone or in combination in patients with the following diagnoses: Group A: NRG1+ NSCLC Group B: mCRPC
Recruiting1 award Phase 2
More about Stephan Kendall, MD
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Stephan Kendall, MD has experience with
- 177Lu-PSMA-617
- ARDT
- Tazemetostat
- Rituximab
- Lenalidomide
- Zenocutuzumab
Breakdown of trials Stephan Kendall, MD has run
Prostate Cancer
Fallopian Tube Cancer
Follicular Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephan Kendall, MD specialize in?
Stephan Kendall, MD focuses on Prostate Cancer and Fallopian Tube Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Stephan Kendall, MD currently recruiting for clinical trials?
Yes, Stephan Kendall, MD is currently recruiting for 5 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Stephan Kendall, MD has studied deeply?
Yes, Stephan Kendall, MD has studied treatments such as 177Lu-PSMA-617, ARDT, Tazemetostat.
What is the best way to schedule an appointment with Stephan Kendall, MD?
Apply for one of the trials that Stephan Kendall, MD is conducting.
What is the office address of Stephan Kendall, MD?
The office of Stephan Kendall, MD is located at: Utah Cancer Specialists, Salt Lake City, Utah 84106 United States. This is the address for their practice at the Utah Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.